Why Are Pharma Stocks Rising?
Best pharma stocks in IndiaYesterday, I was reading the second part of Amish Tripathi’s famous Shiva Trilogy – The Oath of The Vayputras. I came across an interesting quote in…
Cipla’s Profit After Tax Up 11% To Rs 789 Crore
Cipla: In terms of sales, Indian business went up 6.1 per cent in the September quarter.Mumbai: Pharmaceutical firm Cipla has announced a 10.9 per cent growth in its profit after…
Dr Reddy’s, Cipla, Aurobindo Units Recall Products From US Market
Dr Reddy’s initiated the Class III voluntary recall on September 14 this year.(File)New Delhi: Leading drug firms Dr Reddy’s Laboratories, Cipla and Aurobindo Pharma are recalling different products in the…
Cipla Q3 Profit Dips 2.6% To Rs 729 Crore
Cipla’s net profit for third quarter witnessed a slideNew Delhi: Drug major Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729…
Cipla Records Rs 712 Crore Net Profit In September Quarter
Drug maker Cipla recorded a rise in its net profit for the September quarter period of 2021-22Drug manufacturer Cipla on Tuesday recorded a 7.6 per cent rise in its consolidated…
Stocks To Watch: Reliance Industries, IRCTC, Cipla
The Drugs Controller General of India has granted Moderna’s local partner Cipla an import licenceThe domestic stock markets are likely to open in the green in line with positive global…
Cipla Close To Commit Over $1 Billion For Moderna Booster Vaccine In India: Report
Cipla has evinced interest to procure 50 million doses from Moderna for 2022. (Representational)New Delhi: Seeking fast-track approvals to bring Moderna’s single-dose COVID-19 booster vaccine in India expeditiously, Cipla has…
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
The second batch of the antibody cocktail will be made available by mid-June, Cipla addedCipla and Roche India have launched Roche India’s antibody drug cocktail in India for treating mild…
Cipla Launches Covid-19 Detection Test Kit ; Shares Gain
ViraGen used for qualitative detection of SARS-CoV-2 will be manufactured by Ubio Biotechnology Systems.Shares of the country’s leading drug maker – Cipla – rose as much as 2.63 per cent…
At ₹68 per tablet, Cipla to soon launch Ciplenza for coronavirus treatment
Indian pharma major Cipla today announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under…